CLINICA 100 TOP 10: Johnson and Johnson
This article was originally published in Clinica
Johnson & Johnson may have been quiet on the medtech M&A front recently, doing more streamlining than buying, but it still succeeded in hanging onto the No 1 spot in the Clinica 100 league table*.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.